You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hycamtin

Showing 1 - 25 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

Terminated
  • Brain and Central Nervous System Tumors
  • Chicago, Illinois
    Rush Cancer Institute at Rush University Medical Center
Jan 5, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)

Completed
  • Gliomas
  • New York, New York
    Columbia University Irving Medical Center
Jun 30, 2022

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)

Suspended
  • Neoplasm
  • SGT-53
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)

Recruiting
  • Retinoblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 25, 2022

Eye Cancer, Retinoblastoma Trial in Lausanne (Topotecan, Melphalan)

Recruiting
  • Eye Cancer, Retinoblastoma
  • Lausanne, Switzerland
    CHUV Lausanne University Hospital
Nov 18, 2021

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Solid Tumors Trial in Canada (Topotecan and Pazopanib)

Completed
  • Solid Tumors
  • Topotecan and Pazopanib
  • Calgary, Alberta, Canada
  • +9 more
Jun 27, 2022

Retinoblastoma, Retinal Tumor Trial in Memphis (procedure, drug, radiation, other)

Active, not recruiting
Has Results
  • Retinoblastoma
  • Retinal Neoplasm
  • Enucleation
  • +9 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 10, 2022

Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,

Recruiting
  • Relapsed Ewing Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 27, 2021

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +4 more
  • Los Angeles, California
  • +8 more
Jan 31, 2023

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Nemvaleukin and Pembrolizumab Combination
  • +6 more
  • Ventura, California
  • +7 more
Aug 5, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Phoenix, Arizona
  • +2 more
Jun 27, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)

Recruiting
  • Malignant Rhabdoid Tumor
  • Atypical Teratoid Rhabdoid Tumor
  • Los Angeles, California
  • +10 more
Aug 1, 2022

Small Cell Lung Cancer SCLC Trial in München Gauting (veliparib, Topotecan)

Recruiting
  • Small Cell Lung Cancer SCLC
  • München Gauting, Germany
    Klinik München Gauting
Jan 26, 2021

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Phoenix, Arizona
  • +14 more
Sep 1, 2022